Medicines Expertise

FIP Development Goal 14 Education & Workforce Element 

Globally, we will have: 

Strategies and systems in place to prepare and train a workforce that can deliver quality medicines expertise.

Mechanisms

  • Ensure academic capacity (FIP Development Goal 1 [w]) to deliver education and training to enhance medicines expertise in initial education.
  • Incorporate expert information and advice provision skills in early career training strategy (FIP Development Goal 2 [w]) and continuing professional development strategies (FIP Development Goal 9).
  • Utilise advanced and specialist development systems and frameworks (FIP Development Goal 4 [w]) to develop medicines expertise as an advanced or specialist area for the workforce, in addition to being embedded within leadership development programmes (FIP Development Goal 6 [w]).
  • Incorporate medicines expertise competencies and skills in competency development frameworks for pharmacy (FIP Development Goal 5 [w]).

FIP Development Goal 14 Practice Element 

Globally, we will have: 

Strategies and systems in place on pharmaceutical expert information and advice provision to patients, formal and informal caregivers, health care professionals and relevant agencies and stakeholders.

Mechanisms

  • Provide medicines and medical devices expertise and advice to patients, formal and informal caregivers, health care professionals and relevant agencies and stakeholders to inform policymaking, clinical decision-
    making and prescribing practices, individual health care options and other medicines or medical devices related decisions.
  • Empower patients, formal and informal caregivers, and communities by increasing health literacy towards better care and self-care.
  • Utilise appropriate communication and counselling pathways and skills to provide quality and appropriate information, taking into considerations cultural and language factors and other specific care needs (e.g. people with functional diversity, migrant and refugee populations, etc).
  • Utilise formal resources including formularies and medicines information management systems to convey objective, evidence-based and systematically organised information about medicines and medical devices to support pharmacy practice and service delivery, as well as the practice of other healthcare professionals.

FIP Development Goal 14 Science Element 

Globally, we will have: 

Encourage provision of science-based information on medicines.

Mechanisms

  • Promote responsible use of medicines by mobilising medicines expertise.
  • Implement high-value cognitive services to review and optimise medicines use.

Community pharmacists have a crucial role to play in responsible over-the-counter pain management (2021)

Read Publication

Patient Safety: Pharmacists’ role in “Medication without harm” (2020)

Read Publication

FIP Statement of Policy on Medicines Shortages (2020)

Read Publication

Medicines use review: A toolkit for pharmacists (2020)

Read more

Medicines reconciliation: A toolkit for pharmacists (2021)

Read more

Joint Statement by the International Pharmaceutical Federation (FIP) and The World Self-Medication Industry (WSMI): Responsible Self-Medication (1998)

Read more

Joint Statement by the International Pharmaceutical Federation (FIP) and The World Self-Medication Industry (WSMI): Responsible Self-Medication (1999)

Read more

FIP Statement of Policy: Medicines Information for Patients (2008)

Read more

FIP Statement of Policy: Strategic development of medicines information for the benefit of patients and users of medicines (2017)

Read more

FIP Statement of Policy: Pharmacy - Gateway to Care (2017)

Read more

Antibody drug conjugates new cancer treatments on the horizon (2017)

Read more

Use of medicines by the elderly: The role of pharmacy in promoting adherence (2018)

Read more

Artificial Intelligence in Drug Development and Clinical Trials

Register Now!

Use of doxycycline for the prevention of bacterial sexually transmitted infections (STIs) (DoxyPEP): Supporting evidence and the challenge of antimicrobial resistance (AMR)

Register Now!

Alcohol consumption and dependence: The role of pharmacists in prevention, support and management

Reframing the role and impact of pharmacy in Chronic Obstructive Pulmonary Disease (COPD) Care

Reframing the role and impact of pharmacy in chronic disease care

Empowering pharmacists in menopause care: Expanding roles and patient support

Use of heat therapy for the management of musculoskeletal pain in the community pharmacy: New FIP guidance

The role of pharmacists in the management of anticoagulation treatments

Reframing the role and impact of pharmacy in heart failure care

Empoderar a los farmacéuticos para apoyar la deshabituación tabáquica en la región de las Américas

Empowering pharmacists to support tobacco cessation in Europe

Empowering pharmacists to support tobacco cessation in Africa

Empowering pharmacists to support tobacco cessation in the Eastern Mediterranean Region

Empowering pharmacists to support tobacco cessation in Southeast Asia

Empowering pharmacists to support tobacco cessation in Western Pacific Region

Leveraging pharmacists for tobacco cessation: New policy tools, evidence, and success stories

Register Now!

How can pharmacists support patients with co-morbidities in preventing fatty liver disease?

How can pharmacists support individuals living with fatty liver disease?

In this second episode of FIP’s CPD bite series on self-care approaches for fatty liver disease management explores how pharmacists can support a holistic approach to the care of patients with fatty liver disease.


What is fatty liver disease and who is most at risk of developing it? (available in Polish and Romanian subtitles)

In this first episode of this FIP CPD bite series on self-care approaches for fatty liver disease management shares an overview of the epidemiology of fatty liver disease, its pathophysiology, its global burden, and the main risk groups and risk factors. 

The role of pharmacists in the prevention and management of periodontal disease and other common oral health conditions

Obesity: understanding the disease, nutritional approaches and new pharmacological interventions

Ethics of Sustainable Healthcare

Optimising cancer care: community pharmacy strategies to support patients on oral treatment

Climate change and vector-borne neglected tropical diseases: Positioning pharmacy practice to drive awareness, prevention and management

Role of the Pharmacist in the Management of Heart Failure

The role of pharmacists in chronic kidney disease

The role of pharmacists in tobacco cessation

The role of pharmacists in the prevention and management of stress

The role of pharmacists in the prevention and management of sleep disorders

Latest developments on the causes of symptomatic reflux

This video discusses the pharmacological options for managing reflux. You will learn about the different types of medicines, their mechanisms of action, and some advantages and disadvantages of the traditional approaches to these symptoms.

Symptoms of gastro-oesophageal reflux disease

This video explores the treatment options for reflux, including lifestyle changes, dietary modifications, and the use of non-prescription medicines. It shows some considerations that can be useful when approaching patients with reflux symptoms

Biorelevant Dissolution Testing

Provision of medical advice

This episode focuses on the provision of medical advice and the ethical dilemmas that pharmacists can face

Non-pharmacological treatment approaches

This video focuses on non-pharmacological approaches to sore throat management and presents some tips for pharmacists to support self-care in this area.

Pharmacological treatment approaches

This video summarises the main pharmacological treatment approaches for sore throat, focusing on an overview of the different preparations pharmacists can recommend when advising on sore throat management

The patient voice in generic medicine development

Pharmacological approaches and treatments for chronic bronchitis

In this video you may learn about pharmacological approaches and treatments for chronic bronchitis

Facilitating access to medicines: Biowaiver regulatory case studies from Latin America

RNA-based medicines for unmet medical needs

The management of constipation by community pharmacists

Bioequivalencia

The role of pharmacists in oral health

Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults

The role of community pharmacies in COVID-19 booster vaccination: Opportunities and supply chain challenges in a post-pandemic scenario

Precision Medicine: The current status

Precision Medicine: what will it cost?

Register here!

In Vitro In Vivo (IVIV) Correlations: Establishing a correlation between in vitro tests and in vivo product performance

FIP “Setting goals for the decade ahead” | Episode 20 | FIP DG 14: Medicines expertise

Transforming pharmacy practice for improved care and management of diabetes

What technology can bring to cytotoxic drugs compounding

Diabetes therapeutics, treatment optimisation and support technology

mRNA Technology for Vaccines & Therapeutics

Trusted for health- Pharmacy, Medication Adherence & Communication

Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Europe region

Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Eastern Mediterranean Region

Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Southeast Asia region

Optimising opioid use through pharmacists

FIP Guidelines for Dissolution Testing of Solid Oral Products

Medicines regulation beyond product licensing

Register here!

Manufacturing Classification System for oral solid dosage forms: Good in theory and in practice

Register here!

Manufacturing Classification System for oral solid dosage forms: Good in Theory and in Practice

The pharmacy practice research journey – Moving from your research idea to publication

Register here!

The pharmacy practice research journey – Moving from your research idea to publication

Pharmacy Practice Research Showcase

Register here!

Pharmacy Practice Research Showcase

American Association of Pharmaceutical Scientists annual meeting

Annual meeting

EUFEPS annual meeting

EUFEPS is proud and happy to announce the 2019 Annual Meeting to be held in Frankfurt, Germany between March 6 - 8, 2019

AACP Annual Meeting

Shelf life and compounding: rationale and safe measures to mitigate drug shortages

Bob DeChristoforo, USA, Session A2, FIP congress Bangkok 2014

The following FIP programmes of work and structures support the implementation of this Goal:

FIP SIG: Drug Delivery and Manufacturing 

FIP SIG: New Medicines 

FIP SIG: Personalised and Precision Medicine